Tag: Infinity Announces Second Publication on PI3K-Gamma in Nature
Infinity Announces Second Publication on PI3K-Gamma in Nature
-- Inhibition of PI3K-Gamma by IPI-549 Can Reverse Tumor Resistance to Checkpoint Inhibitors in Preclinical Models --
CAMBRIDGE, Mass., Nov. 9, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced the publication of new findings...